COMMUNIQUÉS West-GlobeNewswire

Theratechnologies nomme un nouveau membre à son conseil d’administration
15/10/2018
MONTRÉAL, 15 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de M. Gary Littlejohn à titre d’administrateur indépendant du conseil d’administration de la [...]
Apotheca Biosciences (PCFP) Announces Addition of Dr. Mali Reddy, Seven Time Nobel Prize Nominee, as Chief Medical Adviser & Medical Researcher
15/10/2018
SAINT PETERSBURG, FL, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
EDAP TMS SA : EDAP Announces Expiration of Tranche of Outstanding Warrants
15/10/2018
Warrants for Approximately 3.3 Million Ordinary Shares in the Form of American Depository Shares Expired on October 14, 2018 LYON, France, October 15, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global [...]
XORTX Announces New Clinical Advisory Board Members
15/10/2018
CALGARY, Alberta, Oct. 15, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Athenex and Xiangxue Life Sciences Announce Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy (TAEST) Showed Encouraging Positive Clinical Signals
15/10/2018
BUFFALO, N.Y., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Aravive Biologics and Versartis Complete Merger
15/10/2018
The combined company, Aravive, Inc., to trade on Nasdaq under ticker symbol “ARAV” beginning October 16, 2018, concurrent with a 1-for-6 reverse split of common shares HOUSTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Aravive [...]
Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292 for the Treatment of RET Fusion-Positive Thyroid Cancer
15/10/2018
STAMFORD, Conn., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
15/10/2018
- The first long-lasting, FDA approved micro-insert for up to three years of continuous control in chronic, non-infectious posterior segment uveitis, the third leading cause of blindness in the U.S. - Company to host [...]
Tetra Bio-Pharma Names Dr. Guy Chamberland as Chief Executive Officer and Chief Scientific Officer
15/10/2018
ORLEANS, Ontario, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the permanent appointment of [...]
Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm
15/10/2018
Bagsværd, Denmark, 15 October 2018 - Novo Nordisk A/S today announced the appointment of Ludovic Helfgott as executive vice president of Biopharm, effective 3 April 2019. Based in Zürich, Switzerland, Helfgott will lead [...]
Hygiene Drive at Doug Disraeli D.D.S. Dental Office Aims to Provide Much Needed Items for Homeless in Uptown San Diego – Goal is to Donate 1000 Toothbrushes
15/10/2018
SAN DIEGO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Dental health is critical for all people, including those who are homeless, and to show support for the organizations assisting those in Uptown San Diego and Hillcrest, Dr. [...]
Dynavax Technologies and Quantum Leap Healthcare Collaborative Announce Selection of SD-101 Combined with KEYTRUDA® (pembrolizumab) in the I-SPY 2 TRIAL For Breast Cancer
15/10/2018
BERKELEY, Calif. and SAN FRANCISCO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) and Quantum Leap Healthcare Collaborative™ (QLHC) announced today that the immunotherapy combination [...]
RavenQuest Launches Recreational Brands, Introduces Eight Unique “Experiences” for the Adult Recreational Consumer
15/10/2018
VANCOUVER, British Columbia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) is proud to introduce two distinct flagship brands, both of [...]
Canopy Rivers Announces Significant Contract Manufacturing Agreement Between Portfolio Partners PharmHouse and TerrAscend
15/10/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (“ Canopy Rivers ” or the “ Company ”) (TSXV:RIV) is pleased to announce PharmHouse Inc [...]
Zealand grants new warrants under employee warrant program
15/10/2018
Company announcement - No. 26/2018 Zealand grants new warrants under employee warrant program Copenhagen, October 15, 2018 - Zealand Pharma ("Zealand") announces the granting of warrants to the Company's Senior Vice [...]
Orphazyme endorses patient advocacy consensus guidelines, highlights importance of collaboration with patient communities
15/10/2018
Orphazyme A/S Investor News No. 12/2018 Company Registration No. 32266355 Orphazyme supports consensus guidelines to direct interactions with rare disease patient advocacy organizations Company extends heartfelt [...]
Chairman of the Board will not seek re-election
15/10/2018
Company announcement no.15/2018 For further information please contact: Martin Riise, Head of Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 About Chr. Hansen Chr. [...]
Annual Report 2017/18
15/10/2018
Company announcement no.14/2018 For further information, please contact: Head of IR Martin Riise Tel.: +45 5339 2250 dkmari@chr-hansen.com IR Officer Annika Stern Tel.: +45 2399 2382 dkaste@chr-hansen.com FORWARD- [...]
Rule 2.9 Announcement
15/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 October 2018 [...]

Pages